BDB001

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
BDB001-201: A Clinical Study of BDB001 in Patients With PD-(L)1 Refractory Solid TumorsNCT04819373Eikon TherapeuticsPhase 2Completed2023-04-01Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.